Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds
dc.authorid | KAYA, Mustafa Oguzhan/0000-0002-8592-1567 | |
dc.authorid | Gencer, Nahit/0000-0001-7092-8857 | |
dc.authorid | ARSLAN, Mustafa/0000-0003-0796-4374 | |
dc.contributor.author | Celik, Fatma | |
dc.contributor.author | Arslan, Mustafa | |
dc.contributor.author | Kaya, Mustafa Oguzhan | |
dc.contributor.author | Yavuz, Emre | |
dc.contributor.author | Gencer, Nahit | |
dc.contributor.author | Arslan, Oktay | |
dc.date.accessioned | 2024-12-24T19:30:59Z | |
dc.date.available | 2024-12-24T19:30:59Z | |
dc.date.issued | 2014 | |
dc.department | Siirt Üniversitesi | |
dc.description.abstract | A new series of tetrazole-, oxadiazole-and cyanosubstituted 1,4-dihydropyrimidinone compounds were synthesized, and their inhibitory effects on the activity of purified human carbonic anhydrase (hCA) I were evaluated. 4-Cyanophenyl-1,4- dihydropyrimidinone compounds were prepared with 1,3-diketone, cyanobenzaldehyde and urea. The compounds were reacted with sodium azide and then with anhydride to get the final products. The results showed that all the synthesized compounds inhibited the CA isoenzyme activity. The compound 4-(1,7,7-trimethyl-2,5-dioxo-1,2,3,4,5,6,7,8-octahydroquinazoline- 4-yl) benzonitrile 6c (IC50 = 0.0547 mM) has the most inhibitory effect. | |
dc.description.sponsorship | Research Fund of the Sakarya University [2010-02-04-013] | |
dc.description.sponsorship | This work was supported by Research Fund of the Sakarya University. Project Number: 2010-02-04-013. | |
dc.identifier.doi | 10.3109/21691401.2013.769448 | |
dc.identifier.endpage | 62 | |
dc.identifier.issn | 2169-1401 | |
dc.identifier.issn | 2169-141X | |
dc.identifier.issue | 1 | |
dc.identifier.pmid | 23419142 | |
dc.identifier.scopus | 2-s2.0-84892699256 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 58 | |
dc.identifier.uri | https://doi.org/10.3109/21691401.2013.769448 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12604/7759 | |
dc.identifier.volume | 42 | |
dc.identifier.wos | WOS:000329845100008 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Informa Healthcare | |
dc.relation.ispartof | Artificial Cells Nanomedicine and Biotechnology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241222 | |
dc.subject | carbonic anhydrase | |
dc.subject | dihydropyrimidinone | |
dc.subject | enzyme | |
dc.subject | inhibitor | |
dc.subject | oxadiazole | |
dc.subject | tetrazole | |
dc.title | Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds | |
dc.type | Article |